Novo Nordisk CEO says Wegovy oral tablets account for about 80% of new patient initiations
智通财经2026/11/04 07:30Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Novo Nordisk (NVO.US) CEO: Wegovy oral tablets still account for approximately 80% of the initial medication share among new oral patients.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$78,247.8
+2.05%
Ethereum
ETH
$2,318.88
+2.78%
Tether USDt
USDT
$0.9986
+0.04%
BNB
BNB
$703.86
+1.70%
XRP
XRP
$1.28
+2.10%
USDC
USDC
$0.9999
+0.03%
Solana
SOL
$93.26
+1.47%
TRON
TRX
$0.3219
+0.34%
Zcash
ZEC
$1,291.43
+13.81%
Hyperliquid
HYPE
$85.82
+2.79%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now